Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.41 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 3/20 | 0.41 |
| ▸ | ACE | P12821 | 3/20 | 0.39 |
| ▸ | TRHR | P34981 | 1/20 | 0.38 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.37 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.37 |
| ▸ | PRCP | P42785 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7351804 | 1.00 | MAPK8 (0.41) | MAPK8MAPK9MAPK10KDM1AACE | |
| SCHEMBL29442098 | 0.93 | KDM1A (0.47) | MAPK8MAPK9MAPK10KDM1AEPHA2 | |
| SCHEMBL29548952 | 0.93 | KDM1A (0.48) | MAPK8MAPK9MAPK10KDM1AEPHA2 | |
| SCHEMBL29855959 | 0.93 | KDM1A (0.47) | MAPK8MAPK9MAPK10KDM1AACE | |
| SCHEMBL31437200 | 0.93 | MAPK8 (0.41) | MAPK8MAPK9MAPK10KDM1AEPHA2 | |
| SCHEMBL29607893 | 0.93 | KDM1A (0.48) | MAPK8MAPK9MAPK10KDM1AACE | |
| SCHEMBL6384984 | 0.92 | MAPK8 (0.41) | MAPK8MAPK9MAPK10KDM1AACE | |
| SCHEMBL6384987 | 0.92 | MAPK8 (0.41) | MAPK8MAPK9MAPK10KDM1AACE | |
| SCHEMBL31437174 | 0.92 | MAPK8 (0.40) | MAPK8MAPK9MAPK10KDM1AEPHA2 | |
| SCHEMBL29837381 | 0.91 | MAPK8 (0.43) | MAPK8MAPK9MAPK10KDM1AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022156190-A1 | ANTIHYPERTENSIVE PEPTIDE, LONG-ACTING ANTIHYPERTENSIVE PEPTIDE, AND PREPARATION METHODS THEREFOR | 南方海洋科学与工程广东省实验室(湛江) | 2022-07-28 | — | — | WO | claimed |
| US-12618845-B2 | Methods and compositions for protein sequencing | Quantum-Si Incorporated (US) | 2026-05-05 | — | — | US | disclosed |
| US-20250283886-A1 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | Quantum-Si Incorporated | 2025-09-11 | — | — | US | disclosed |
| US-12360114-B2 | Methods and compositions for protein sequencing | Quantum-Si Incorporated (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250130238-A1 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | Quantum-Si Incorporated (US) | 2025-04-24 | — | — | US | disclosed |
| US-12259391-B2 | Methods and compositions for protein sequencing | Quantum-Si Incorporated (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| US-12174196-B2 | Methods and compositions for protein sequencing | Quantum-Si Incorporated (US) | 2024-12-24 | — | — | US | disclosed |
| US-20240272169-A1 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | Quantum-Si Incorporated (US) | 2024-08-15 | — | — | US | disclosed |
| US-12055548-B2 | Methods and compositions for protein sequencing | Quantum-Si Incorporated (US) | 2024-08-06 | — | — | US | disclosed |
| WO-2023141679-A1 | DIMERS AND USES THEREFOR | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH (AU) | 2023-08-03 | — | — | WO | disclosed |
| CN-112661811-B | Antihypertensive peptide, long-acting antihypertensive peptide and preparation method thereof | 南方海洋科学与工程广东省实验室(湛江) | 2022-10-21 | — | — | CN | disclosed |
| WO-2022156190-A1 | ANTIHYPERTENSIVE PEPTIDE, LONG-ACTING ANTIHYPERTENSIVE PEPTIDE, AND PREPARATION METHODS THEREFOR | 南方海洋科学与工程广东省实验室(湛江) | 2022-07-28 | — | — | WO | disclosed |
| WO-1998016548-A1 | THROMBIN RECEPTOR PEPTIDES AND USES THEREOF | UNIVERSITY OF MASSACHUSETTS (US) | 1998-04-23 | — | — | WO | disclosed |
| EP-0216891-A1 | A SOLUBILIZABLE, FIBRIN BASED COMPOSITION AND ITS USE. | BIOPOOL AB (SE) | 1987-04-08 | — | — | EP | disclosed |
| WO-1986005814-A1 | A SOLUBILIZABLE, FIBRIN BASED COMPOSITION AND ITS USE, IN DETERMINATIONS OF FIBRINOLYSIS PARAMETERS | BIOPOOL AB (SE) | 1986-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250130238-A1 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | CRYAA, CRYAB, CACYBP | MAPK8 1769/4885MAPK9 1967/4885MAPK10 3404/4885 |
| US-12055548-B2 | Methods and compositions for protein sequencing | CRYAA, CRYAB, CACYBP | MAPK8 1769/4885MAPK9 1967/4885MAPK10 3404/4885 |
| US-12259391-B2 | Methods and compositions for protein sequencing | CRYAA, CRYAB, CACYBP | MAPK8 1725/4885MAPK9 1929/4885MAPK10 3368/4885 |
| US-12174196-B2 | Methods and compositions for protein sequencing | CRYAA, CRYAB, CACYBP | MAPK8 1769/4885MAPK9 1967/4885MAPK10 3404/4885 |
| US-20250283886-A1 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | CRYAA, CRYAB, CACYBP | MAPK8 1769/4885MAPK9 1967/4885MAPK10 3404/4885 |
| US-20240272169-A1 | METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING | CRYAA, CRYAB, CACYBP | MAPK8 1769/4885MAPK9 1967/4885MAPK10 3404/4885 |
| US-12618845-B2 | Methods and compositions for protein sequencing | PTMS, MICA, MAX | MAPK8 592/4885MAPK9 737/4885MAPK10 2140/4885 |
| US-12360114-B2 | Methods and compositions for protein sequencing | CRYAA, CRYAB, CACYBP | MAPK8 1769/4885MAPK9 1967/4885MAPK10 3404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.